Atovaquone for Treatment of COVID-19
NCT04456153
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Experimental Group
DRUG:
Placebo Group
Sponsor
University of Texas Southwestern Medical Center